Patents by Inventor Boaz Pal

Boaz Pal has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20100317002
    Abstract: Provided is a method of identifying a genetically abnormal cell in a sputum sample, the method comprising: (a) staining a sputum sample using a morphological stain so as to identify a lower airway tract cell or lung cell in the sputum sample; and (b) staining the sputum sample using fluorescent in situ hybridization (FISH) so as to identify in the lower airway tract cell or lung cell a genetic abnormality in at least one of human chromosome 3p22.1 and 10q22-23, thereby identifying the genetically abnormal cell in the sputum sample. Also provided are methods and kits of diagnosing lung cancer by detecting a presence of genetically abnormal cells above a predetermined threshold in a sputum sample.
    Type: Application
    Filed: October 6, 2008
    Publication date: December 16, 2010
    Applicant: Bioview Ltd.
    Inventors: Michal Daniely, Lea Madi, Tal Kaplan, Boaz Pal, Yuval Harari, Tanweer M. Zaidi, Ricardo L. Fernandez, Jinping Zhang, Ruth Katz
  • Publication number: 20100099687
    Abstract: This invention relates to oral pharmaceutical compositions suitable for making pharmaceutical formulations for oral administration that provide for the rapid dissolution of the phosphodiesterase 5 inhibitor tadalafil. In particular, the pharmaceutical compositions comprise solid composites of tadalafil exhibiting high solubility and rate of dissolution. The invention further relates to methods of preparing these pharmaceutical formulations and the use of such pharmaceutical formulations for treating diseases associated with PDE5 inhibitors.
    Type: Application
    Filed: December 23, 2009
    Publication date: April 22, 2010
    Applicant: Teva Pharmaceutical Industries Ltd.
    Inventors: Ilan ZALIT, Boaz PAL
  • Publication number: 20090324718
    Abstract: Provided are compositions of imatinib, methods for their preparation, and methods for treatment using the same.
    Type: Application
    Filed: September 4, 2007
    Publication date: December 31, 2009
    Inventors: Ilan Zalit, Boaz Pal
  • Publication number: 20080009502
    Abstract: This invention relates to oral pharmaceutical compositions suitable for making pharmaceutical formulations for oral administration that provide for the rapid dissolution of the phosphodiesterase 5 inhibitor tadalafil. In particular, the pharmaceutical compositions comprise solid composites of tadalafil exhibiting high solubility and rate of dissolution. The invention further relates to methods of preparing these pharmaceutical formulations and the use of such pharmaceutical formulations for treating diseases associated with PDE5 inhibitors.
    Type: Application
    Filed: November 9, 2006
    Publication date: January 10, 2008
    Inventors: Ilan Zalit, Boaz Pal
  • Publication number: 20070275075
    Abstract: Provided are ezetimibe compositions with improved solubility and increased bioavailability, methods of their preparation, and method of treatment using the same. An ezetimibe composition may be prepared, for example, by co-milling ezetimibe with at least one hydrophilic excipient.
    Type: Application
    Filed: March 6, 2007
    Publication date: November 29, 2007
    Inventors: Ilan Zalit, Boaz Pal